We are live on ! Find out more
EMFAT

Emerald Mutual Fund Advisers Trust Portfolio holdings

AUM $2.06B
1-Year Est. Return 106.87%
This Fund
S&P 500
This Quarter Est. Return
+8.18%
1 Year Est. Return
+106.87%
3 Year Est. Return
+347.49%
5 Year Est. Return
+440.43%
10 Year Est. Return
+3,482.63%
AUM
$2.29B
AUM Growth
+$108M
Cap. Flow
-$6.92M
Cap. Flow %
-0.3%
Top 10 Hldgs %
15.3%
Holding
287
New
27
Increased
48
Reduced
38
Closed
29

Sector Composition

Rank Sector Weight
1 Financials 26.1%
2 Technology 16.69%
3 Industrials 15.06%
4 Healthcare 12.66%
5 Consumer Discretionary 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAOI icon
76
Applied Optoelectronics
AAOI
$7.57B
$10.7M 0.47%
172,818
-79,357
-31% -$4.64M
EGBN icon
77
Eagle Bancorp
EGBN
$836M
$10.6M 0.46%
167,748
BFYT
78
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
$10.6M 0.46%
448,955
+50,000
+13% +$998K
IOSP icon
79
Innospec
IOSP
$2.12B
$10.2M 0.44%
154,962
GTHX
80
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$10.1M 0.44%
+578,057
New +$10.1M
ADMS
81
DELISTED
Adamas Pharmaceuticals
ADMS
$10M 0.44%
571,789
ABCB icon
82
Ameris Bancorp
ABCB
$5.88B
$9.94M 0.43%
206,237
MXL icon
83
MaxLinear
MXL
$6.17B
$9.87M 0.43%
354,040
+11,340
+3% +$330K
EWBC icon
84
East-West Bancorp
EWBC
$18B
$9.53M 0.42%
162,663
MTUS icon
85
Metallus
MTUS
$838M
$9.53M 0.42%
619,765
-2,300
-0.4% -$34.1K
FFWM
86
DELISTED
First Foundation Inc
FFWM
$9.5M 0.41%
578,105
+294,031
+104% +$4.69M
SFBS
87
ServisFirst Bancshares
SFBS
$4.9B
$9.45M 0.41%
256,130
AIMT
88
DELISTED
Aimmune Therapeutics
AIMT
$9.44M 0.41%
459,160
SIVB
89
DELISTED
SVB Financial Group
SIVB
$9.35M 0.41%
53,199
-22,326
-30% -$4M
STL
90
DELISTED
Sterling Bancorp
STL
$9.3M 0.41%
400,023
+214,740
+116% +$4.92M
RETA
91
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$9.3M 0.41%
293,927
+19,235
+7% +$473K
CSFL
92
DELISTED
CenterState Bank Corporation Common Stock
CSFL
$9.2M 0.4%
370,213
+166,890
+82% +$4.15M
WAL icon
93
Western Alliance Bancorporation
WAL
$8.84B
$9.19M 0.4%
186,834
RRGB icon
94
Red Robin
RRGB
$145M
$9.13M 0.4%
140,006
+93,535
+201% +$5.94M
BOX icon
95
Box
BOX
$4.37B
$9.08M 0.4%
+497,780
New +$8.98M
BHVN
96
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$8.81M 0.38%
+352,560
New +$8.12M
CLF icon
97
Cleveland-Cliffs
CLF
$6.59B
$8.8M 0.38%
1,271,072
-48,633
-4% -$322K
ITGR icon
98
Integer Holdings
ITGR
$3.44B
$8.63M 0.38%
199,617
-184,348
-48% -$7.34M
MODN
99
DELISTED
MODEL N, INC.
MODN
$8.62M 0.38%
648,075
PLAY icon
100
Dave & Buster's
PLAY
$378M
$8.44M 0.37%
126,913

Similar funds

Emerald Mutual Fund Advisers Trust's Q2 2017 Portfolio in Review

As of Q2 2017, Emerald Mutual Fund Advisers Trust held 287 positions worth $2.29B, up 4.9% from $2.19B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Emerald Mutual Fund Advisers Trust's Q2 2017 filing shows 27 new, 48 increased, 38 reduced and 29 closed positions. Its largest new stake was Hostess Brands, Inc. Class A Common Stock: 1,231,883 shares worth $19.8M. The largest sale was Veeva Systems, an estimated $36.9M.

By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 26% a quarter earlier, followed by Technology and Industrials.

  • Emerald Mutual Fund Advisers Trust's largest Q2 2017 buy was Hostess Brands, Inc. Class A Common Stock: 1,231,883 shares worth $19.8M.
  • Emerald Mutual Fund Advisers Trust added most to bluebird bio in Q2 2017, an estimated $10.3M increase.
  • Emerald Mutual Fund Advisers Trust's biggest Q2 2017 reduction was Veeva Systems, cutting an estimated $36.9M.
  • Emerald Mutual Fund Advisers Trust fully exited Exelixis in Q2 2017, selling an estimated $12.2M.
  • Emerald Mutual Fund Advisers Trust's ten largest holdings make up 15% of its $2.29B portfolio in Q2 2017.
  • Emerald Mutual Fund Advisers Trust opened 27 new positions and closed 29 in Q2 2017.
  • Emerald Mutual Fund Advisers Trust's portfolio value rose 4.9% quarter-over-quarter to $2.29B.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q2 2017, filed 28 Jul 2017.